US patient receives Israeli coronavirus treatment with100% survival rate – Jewish Ledger
(JNS) An American patient diagnosed with the coronavirus (COVID-19) has been given a treatment by Israeli-based Pluristem that, so far, has a 100 percent survival rate.
The development, which occurred under the Israel s compassionate-use program, comes days after the company released preliminary data showing that six critically ill coronavirus patients in the Jewish state who are considered high-risk received the Haifa-based company s placental cell-therapy treatment and survived one week later. The patient, whose condition was similar to the Israeli ones, was treated with Pluristem s PLX cell therapy at Holy Name Medical Center in New Jersey, where the company is conducting a Phase III critical limb ischemia study.
Those darn Israelis.